The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 3, 2006, Pages 361-367

  Hirose, Takashi ^a   Mizutani, Yoshihide ^a   Ohmori, Tohru ^b   Ishida, Hiroo ^a   Hosaka, Takamichi ^a   Ando, Kohichi ^a   Shirai, Takao ^a   Okuda, Kentaro ^a   Ohnishi, Tsukasa ^a   Horichi, Naoya ^a   Kubota, Hayato ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Concurrent thoracic radiotherapy; Locally advanced non small cell lung cancer; Vinorelbine

Indexed keywords

AMINOTRANSFERASE; CISPLATIN; CORTICOSTEROID; CREATININE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; INFECTION; INOPERABLE CANCER; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; STOMACH ULCER; SURVIVAL TIME; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION DOSAGE; THORAX; TREATMENT OUTCOME; VINBLASTINE;

EID: 33744454668     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0164-7     Document Type: Article

References (26)

1. Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T, Cole B, Kennedy T (1998) Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 16:3316-3322
2. Cros S, Wright M, Morimoto M, Lataste H, Couzinier JP, Krikorian A (1989) Experimental antitumor activity of navelbine. Semin Oncol 16(suppl 4):15-20
3. Curren WJ, Scott CB, Langer CL, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Sause W, Cox JD (2003) Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 22:621
4. Depierre A, Lemarie E, Dabouis G, Garnier G, Jacoulet P, Dalphin JC (1991) A phase II study of navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol 14:115-119
5. Dewit L (1987) Combined treatment of radiation and cis-diammine- dichloroplatinum II: A review of experimental and clinical data. Int J Radiat Oncol Bio Phys 13:403-426
6. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR (1996) Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) trial. J Natl Cancer Inst 88:1210-1215
7. Edelman MJ, Gandara DR (1996) Promising new agents in the treatment of non-small cell lung cancer. Cancer Chemother Pharmacol 37:385-393
8. Edelstein MP, Wolfe LA III, Duch DS (1996) Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Semin Oncol 23:41-47
9. Furuse K, Fukuoka M, Kawahara M, Nishiwaki H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699
10. Goa KL, Faulds D (1994) Vinorelbine-a review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs Aging Adis Int 5:200-234
11. Kelly K, Crowley J, Burn PA Jr, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara D (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell-lung-cancer: a Southwest Oncology Group trial. J Clin Oncol 19:3210-3218
12. Kiura K, Ueoka H, Segawa Y, Tabata M, Kamei H, Takigawa N, Hiraki S, Watanabe Y, Bessho A, Eguchi K, Okimoto N, Harita S, Takemoto M, Hiraki Y, Harada M, Tanimoto M (2003) Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer. Br J Cancer 89:795-802
13. Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J (2001) Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California cancer consortium phase II trial. J Clin Oncol 19:442-447
14. Le Chevalier T, Brisgand D, Douilland JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Gottfried M, Ruffie P, Panizo A, Gaspard MH, Ravaioli A, Besenval M, Besson F, Martinez A, Berthaud P, Tursz T (1994) Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbin alone in advanced non-small cell lung cancer: results of a European multicentre trial including 612 patients. J Clin Oncol 12:360-367
15. Masters GA, Haraf DJ, Hoffman PC, Drinkard LC, Krauss SA, Ferguson MK, Oiak J, Samuels BL, Golomb HM, Vokes EE (1998) Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol 16:2157-2163
16. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trails. BMJ 311:899-909
17. Perez CA, Stanley K, Grundy G, Hanson W, Rubin P, Kramer S, Brady LW, Marks JE, Perez-Tamayo R, Brown GS, Concannon JP, Rotman M (1982) Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 50:1091-1099
18. Pritchard RS, Anthony SP (1996) Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. Ann Intern Med 125:723-729
19. Robert F, Spencer SA, Childs HA III, Zhang R, Meredith RF, Wheeler RH, Hawkins MH, Carey D (2002) Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: long-term follow-up of a phase I trial. Lung Cancer 37:189-199
20. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar AR, Cox JD (1995) Radiation therapy oncology group (RTOG) 88-08 and Eastern cooperative oncology group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198-205
21. Scagliotti GV, Marinis FD, Rinaldi M, Crino L, Gridelli C, Ricci S, Matano E, Boni C, Marangolo M, Failla G, Altavilla G, Adamo V, Ceribelli A, Clerici M, Costanzo FD, Frontini L, Tonato M (2002) Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 20:4285-4291
22. Segawa Y, Ueoka H, Kiura K Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M (2000) A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfactionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama lung cancer study group. Br J Cancer 82:104-111
23. Sekine I, Noda L, Oshita F, Yamada K, Tanaka M, Yamashita K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Sumi M, Saijo N (2004) Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Cancer Sci 95:691-695
24. Solomon B, Ball DL, Richardson G, Smith JG, Millward M, Macmanus M, Michael M, Wirth A, Okane C, Muceniekas L, Ryan G, Rischin D (2003) Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer. Lung Cancer 41:353-361
25. Vokes EE, Herndon JE II, Crawford J, Leopold KA, Perry MC, Miller AA, Green MR (2002) Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 20:4191-4198
26. Zatloukal PV, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L (2004) Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46:87-98